These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31169973)

  • 1. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p.
    Wang X; Zou J; Chen H; Zhang P; Lu Z; You Z; Sun J
    IUBMB Life; 2019 Oct; 71(10):1482-1491. PubMed ID: 31169973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C; Zhu LX; Sun DM; Yao H; Han DX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p.
    Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q
    Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00612 functions as a ceRNA for miR-214-5p to promote the proliferation and invasion of osteosarcoma in vitro and in vivo.
    Zhou Y; Li X; Yang H
    Exp Cell Res; 2020 Jul; 392(1):112012. PubMed ID: 32311343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p].
    Gao Y; Luo X; Liao P; Luo Y
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):479-486. PubMed ID: 37653011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
    Zhou Y; Yin L; Li H; Liu LH; Xiao T
    Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
    [No Abstract]   [Full Text] [Related]  

  • 10. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
    Wang L; Li S; Qi L; Ling L
    Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00313 Knockdown Inhibits Tumorigenesis and Metastasis in Human Osteosarcoma by Upregulating FOSL2 through Sponging miR-342-3p.
    Chen H; Wahafu P; Wang L; Chen X
    Yonsei Med J; 2020 May; 61(5):359-370. PubMed ID: 32390359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMSC-EV-derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP
    Feng D; Li Z; Yang L; Liang H; He H; Liu L; Zhang W
    Oxid Med Cell Longev; 2022; 2022():8825784. PubMed ID: 35281474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
    Chen T; Qin S; Gu Y; Pan H; Bian D
    Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway.
    Chen Y; Cao K; Li J; Wang A; Sun L; Tang J; Xiong W; Zhou X; Chen X; Zhou J; Liu Y
    Cancer Med; 2019 Apr; 8(4):1744-1754. PubMed ID: 30843652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
    Xue Y; Liu H; Nie G; Ren X
    Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
    Peng Y; Leng W; Duan S; Hong M
    Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression.
    Wang B; Xu Z; Wang X; Xia S; Cai P; Wang M; Gao Z
    J Orthop Surg Res; 2022 Feb; 17(1):74. PubMed ID: 35123530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.